Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT vs TP Neoadjuvant Chemotherapy in HER2-negative Early Breast Cancer
NCT04499118Phase 2Unknown
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Aug 2020
- Primary completion
- Aug 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, carboplatin in breast cancer, sponsored by Sichuan Provincial People's Hospital. Status: unknown.
02
Drugs
cisplatincarboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04499118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04499118.